Tanık, V.O.; Akdeniz, E.; Çınar, T.; Şimşek, B.; İnan, D.; Kıvrak, A.; Karabağ, Y.; Çağdaş, M.; Kalkan, K.; Karabay, C.Y.;
et al. Higher C-Reactive Protein to Albumin Ratio Portends Long-Term Mortality in Patients with Chronic Heart Failure and Reduced Ejection Fraction. Medicina 2024, 60, 441.
https://doi.org/10.3390/medicina60030441
AMA Style
Tanık VO, Akdeniz E, Çınar T, Şimşek B, İnan D, Kıvrak A, Karabağ Y, Çağdaş M, Kalkan K, Karabay CY,
et al. Higher C-Reactive Protein to Albumin Ratio Portends Long-Term Mortality in Patients with Chronic Heart Failure and Reduced Ejection Fraction. Medicina. 2024; 60(3):441.
https://doi.org/10.3390/medicina60030441
Chicago/Turabian Style
Tanık, Veysel Ozan, Evliya Akdeniz, Tufan Çınar, Barış Şimşek, Duygu İnan, Ahmet Kıvrak, Yavuz Karabağ, Metin Çağdaş, Kamuran Kalkan, Can Yücel Karabay,
and et al. 2024. "Higher C-Reactive Protein to Albumin Ratio Portends Long-Term Mortality in Patients with Chronic Heart Failure and Reduced Ejection Fraction" Medicina 60, no. 3: 441.
https://doi.org/10.3390/medicina60030441
APA Style
Tanık, V. O., Akdeniz, E., Çınar, T., Şimşek, B., İnan, D., Kıvrak, A., Karabağ, Y., Çağdaş, M., Kalkan, K., Karabay, C. Y., & Özlek, B.
(2024). Higher C-Reactive Protein to Albumin Ratio Portends Long-Term Mortality in Patients with Chronic Heart Failure and Reduced Ejection Fraction. Medicina, 60(3), 441.
https://doi.org/10.3390/medicina60030441
